Cargando…

The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study

OBJECTIVE: RA is a progressive, chronic autoimmune disease. We summarize the impact of disease activity as measured by the DAS in 28 joints (DAS28-CRP scores) and pain on productivity and ability to work using the Work Productivity and Activity Impairment questionnaire (WPAI) scores, in addition to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galloway, James, Capron, Jean-Philippe, De Leonardis, Francesco, Fakhouri, Walid, Rose, Alison, Kouris, Ilias, Burke, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494042/ https://www.ncbi.nlm.nih.gov/pubmed/32964180 http://dx.doi.org/10.1093/rap/rkaa041

Ejemplares similares

Wellbeing and Arthritis Incidence: the Survey of Health, Ageing and Retirement in Europe
por: Okely, Judith A., et al.
Publicado: (2016)

Health and Retirement in Europe
por: Hagan, Ronald, et al.
Publicado: (2009)

New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review
por: Caporali, Roberto, et al.
Publicado: (2020)

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
por: Fakhouri, Walid, et al.
Publicado: (2020)

Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
por: Fakhouri, Walid, et al.
Publicado: (2021)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings
por: Perrone, Valentina, et al.
Publicado: (2021)

Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
por: ten Klooster, Peter M., et al.
Publicado: (2019)

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
por: Van De Laar, Celine J, et al.
Publicado: (2020)

Outpatient visits after retirement in Europe and the US
por: Bíró, Anikó
Publicado: (2016)

Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
por: Perrone, Valentina, et al.
Publicado: (2020)

Work Ability and Quality of Life in Patients with Rheumatoid Arthritis
por: Tański, Wojciech, et al.
Publicado: (2022)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis—going beyond treat to target
por: Taylor, Peter C., et al.
Publicado: (2021)

Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
por: Mohning, Michael P., et al.
Publicado: (2021)

Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis
por: Fautrel, Bruno, et al.
Publicado: (2018)

Factors affecting walking ability in female patients with rheumatoid arthritis
por: Morita, Yugo, et al.
Publicado: (2018)

Nurses’ intention to work after retirement, work ability and perceptions after retirement: a scoping review
por: Kaewpan, Wonpen, et al.
Publicado: (2019)

Impact of transition to retirement on the risk of depression and suicidality: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
por: Mosconi, G, et al.
Publicado: (2023)

POLICY AND ECONOMIC INFLUENCES ON RETIREMENT, FINANCIAL LITERACY, AND ECONOMIC SECURITY IN JAMAICA
por: Davis, Julian G McKoy
Publicado: (2019)

Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
por: Fakhouri, Walid, et al.
Publicado: (2018)

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis
por: Hammond, Alison, et al.
Publicado: (2021)

A Frailty Instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)
por: Romero-Ortuno, Roman, et al.
Publicado: (2010)

Economic Uncertainties in Retirement: Risk Factors, Strategies, and Resilience
por: Bishop, Christine, et al.
Publicado: (2020)

The Influence of Severity and Disease Duration on TNF Receptors’ Redistribution in Asthma and Rheumatoid Arthritis
por: Alshevskaya, Alina, et al.
Publicado: (2022)

Does Transition to Retirement Promote Grandchild Care? Evidence From Europe
por: Tanskanen, Antti O., et al.
Publicado: (2021)

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
por: Dikranian, Ara, et al.
Publicado: (2021)

Longitudinal Predictors of Functional Impairment in Older Adults in Europe – Evidence from the Survey of Health, Ageing and Retirement in Europe
por: Hajek, André, et al.
Publicado: (2016)

Self-rated work ability as a risk factor for disability retirement
por: Kainulainen, Sakari, et al.
Publicado: (2023)

Transition to retirement impact on risk of depression and suicidality: results from a longitudinal analysis of the Survey of Health, Ageing and Retirement in Europe (SHARE)
por: Mosconi, G., et al.
Publicado: (2023)

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
por: Fragoulakis, Vasilis, et al.
Publicado: (2015)

Low-dose rituximab protocol in rheumatoid arthritis—outcome and economic impact
por: Chandramohan, Parvathypriya, et al.
Publicado: (2021)

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis
por: Shafrin, Jason, et al.
Publicado: (2018)

Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Differential Associations of Inflammatory and Endothelial Biomarkers with Disease Activity in Rheumatoid Arthritis of Short Duration
por: Klimek, Ewa, et al.
Publicado: (2014)

Sleep Quality in Patients with Rheumatoid Arthritis and Associations with Pain, Disability, Disease Duration, and Activity
por: Grabovac, Igor, et al.
Publicado: (2018)

The Social Relations and Economic Preparation for Retirement of One-Person Households
por: Sung, Heayoung
Publicado: (2021)

Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project
por: Stoffer, Michaela A, et al.
Publicado: (2014)

Wellbeing and chronic lung disease incidence: The Survey of Health, Ageing and Retirement in Europe
por: Okely, Judith A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h6vpc1g9vvsedmbh1mi4rst8hr